These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 19836351)

  • 41. Down-regulation of Sprouty2 in non-small cell lung cancer contributes to tumor malignancy via extracellular signal-regulated kinase pathway-dependent and -independent mechanisms.
    Sutterlüty H; Mayer CE; Setinek U; Attems J; Ovtcharov S; Mikula M; Mikulits W; Micksche M; Berger W
    Mol Cancer Res; 2007 May; 5(5):509-20. PubMed ID: 17510316
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
    Huang Y; Li X; Jiang J; Frank SJ
    Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activation of MAPK pathways due to DUSP4 loss promotes cancer stem cell-like phenotypes in basal-like breast cancer.
    Balko JM; Schwarz LJ; Bhola NE; Kurupi R; Owens P; Miller TW; Gómez H; Cook RS; Arteaga CL
    Cancer Res; 2013 Oct; 73(20):6346-58. PubMed ID: 23966295
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nicotinamide phosphoribosyltransferase: a potent therapeutic target in non-small cell lung cancer with epidermal growth factor receptor-gene mutation.
    Okumura S; Sasaki T; Minami Y; Ohsaki Y
    J Thorac Oncol; 2012 Jan; 7(1):49-56. PubMed ID: 22089115
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dual-specificity phosphatases are targets of the Wnt/β-catenin pathway and candidate mediators of β-catenin/Ras signaling interactions.
    Zeller E; Mock K; Horn M; Colnot S; Schwarz M; Braeuning A
    Biol Chem; 2012 Oct; 393(10):1183-91. PubMed ID: 23089536
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Docosahexaenoic acid induces apoptosis in lung cancer cells by increasing MKP-1 and down-regulating p-ERK1/2 and p-p38 expression.
    Serini S; Trombino S; Oliva F; Piccioni E; Monego G; Resci F; Boninsegna A; Picci N; Ranelletti FO; Calviello G
    Apoptosis; 2008 Sep; 13(9):1172-83. PubMed ID: 18679798
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prostaglandin E2 activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent manner.
    Krysan K; Reckamp KL; Dalwadi H; Sharma S; Rozengurt E; Dohadwala M; Dubinett SM
    Cancer Res; 2005 Jul; 65(14):6275-81. PubMed ID: 16024629
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Decreased expression of DUSP4 is associated with liver and lung metastases in colorectal cancer.
    Saigusa S; Inoue Y; Tanaka K; Toiyama Y; Okugawa Y; Shimura T; Hiro J; Uchida K; Mohri Y; Kusunoki M
    Med Oncol; 2013; 30(3):620. PubMed ID: 23749251
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Phosphotyrosine Substrate Sequence Motifs for Dual Specificity Phosphatases.
    Zhao BM; Keasey SL; Tropea JE; Lountos GT; Dyas BK; Cherry S; Raran-Kurussi S; Waugh DS; Ulrich RG
    PLoS One; 2015; 10(8):e0134984. PubMed ID: 26302245
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Combined Dusp4 and p53 loss with Dbf4 amplification drives tumorigenesis via cell cycle restriction and replication stress escape in breast cancer.
    Hanna A; Nixon MJ; Estrada MV; Sanchez V; Sheng Q; Opalenik SR; Toren AL; Bauer J; Owens P; Mason FM; Cook RS; Sanders ME; Arteaga CL; Balko JM
    Breast Cancer Res; 2022 Jul; 24(1):51. PubMed ID: 35850776
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of DUSP1 on the apoptotic potential of deoxynivalenol in the epithelial cell line HepG2.
    Casteel M; Nielsen C; Kothlow S; Dietrich R; Märtlbauer E
    Toxicol Lett; 2010 Nov; 199(1):43-50. PubMed ID: 20708668
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mitogen-activated protein kinase phosphatase-1 modulated JNK activation is critical for apoptosis induced by inhibitor of epidermal growth factor receptor-tyrosine kinase.
    Takeuchi K; Shin-ya T; Nishio K; Ito F
    FEBS J; 2009 Mar; 276(5):1255-65. PubMed ID: 19175673
    [TBL] [Abstract][Full Text] [Related]  

  • 53. NNK activates ERK1/2 and CREB/ATF-1 via beta-1-AR and EGFR signaling in human lung adenocarcinoma and small airway epithelial cells.
    Laag E; Majidi M; Cekanova M; Masi T; Takahashi T; Schuller HM
    Int J Cancer; 2006 Oct; 119(7):1547-52. PubMed ID: 16671086
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mitogen-activated protein kinase phosphatase-1 is overexpressed in non-small cell lung cancer and is an independent predictor of outcome in patients.
    Vicent S; Garayoa M; López-Picazo JM; Lozano MD; Toledo G; Thunnissen FB; Manzano RG; Montuenga LM
    Clin Cancer Res; 2004 Jun; 10(11):3639-49. PubMed ID: 15173070
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dasatinib (BMS-354825) selectively induces apoptosis in lung cancer cells dependent on epidermal growth factor receptor signaling for survival.
    Song L; Morris M; Bagui T; Lee FY; Jove R; Haura EB
    Cancer Res; 2006 Jun; 66(11):5542-8. PubMed ID: 16740687
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Functional analysis of MKP-1 and MKP-2 in breast cancer tamoxifen sensitivity.
    Haagenson KK; Zhang JW; Xu Z; Shekhar MP; Wu GS
    Oncotarget; 2014 Feb; 5(4):1101-10. PubMed ID: 24658355
    [TBL] [Abstract][Full Text] [Related]  

  • 57. DUSP4 inhibits autophagic cell death in PTC by inhibiting JNK-BCL2-Beclin1 signaling.
    He H; Du Z; Lin J; Wu W; Yu Y
    Biochem Cell Biol; 2021 Oct; 99(5):554-561. PubMed ID: 33621155
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Activated epidermal growth factor receptor-Stat-3 signaling promotes tumor survival in vivo in non-small cell lung cancer.
    Haura EB; Zheng Z; Song L; Cantor A; Bepler G
    Clin Cancer Res; 2005 Dec; 11(23):8288-94. PubMed ID: 16322287
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Akt kinase-interacting protein1, a novel therapeutic target for lung cancer with EGFR-activating and gatekeeper mutations.
    Yamada T; Takeuchi S; Fujita N; Nakamura A; Wang W; Li Q; Oda M; Mitsudomi T; Yatabe Y; Sekido Y; Yoshida J; Higashiyama M; Noguchi M; Uehara H; Nishioka Y; Sone S; Yano S
    Oncogene; 2013 Sep; 32(37):4427-35. PubMed ID: 23045273
    [TBL] [Abstract][Full Text] [Related]  

  • 60. DUSP26 negatively affects the proliferation of epithelial cells, an effect not mediated by dephosphorylation of MAPKs.
    Patterson KI; Brummer T; Daly RJ; O'Brien PM
    Biochim Biophys Acta; 2010 Sep; 1803(9):1003-12. PubMed ID: 20347885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.